Wearables-US FDA Regulatory Perspective

FDA Perspective on Wearables: Rules for Medical Devices and Wellness Products

Introduction

Wearable devices are gadgets people wear on their bodies, either directly on the skin or built into clothing or accessories. They use sensors, software, and sometimes wireless connections such as Bluetooth or Wi-Fi to collect and sometimes analyze data. They are increasingly common with the general public because they can track a wide range of activities and health-related information.

Health is one of the areas where wearables make the biggest impact. They are used in medical research, clinical care, personal health tracking, and the development of new technology and tools in healthcare and engineering. That range of uses is why FDA regulation of wearables is not one-size-fits-all. A step counter and an ECG monitor can look alike on a wrist, but the FDA treats them very differently.

FDA Perspective on Wearables: What You Need to Know

The FDA does not regulate wearables as a category. It regulates what a product is intended to do. The main points:

• Intended use decides. A wearable intended to diagnose, treat, mitigate, or prevent a disease or condition is a medical device. A wearable intended only for general wellness, with low risk, generally is not regulated as one.
• Function matters more than platform. Whether software is regulated depends on what it does, not on whether it runs on a phone, a watch, or a patch.
• Wearables often do both. Many products mix wellness features and medical features, and the FDA has a policy for how to treat them.
• The wellness line has moved. In January 2026 the FDA revised its General Wellness policy. Non-invasive wearables that estimate physiologic values such as blood pressure, oxygen saturation, or glucose can qualify as wellness products if they are intended only for wellness and avoid disease claims.
• Regulated wearables follow device rules. They need the right premarket pathway, a quality system, labeling, and post-market controls.

Types of Wearables

Wearables share four characteristics:

• Body-worn: worn on the wrist, finger, head, chest, or foot, or embedded in clothing
• Sensor-based: tracks physical parameters such as heart rate, steps, sleep, and oxygen saturation
• Connected: syncs with smartphones or cloud services through Bluetooth, Wi-Fi, or similar links
• Data-driven: uses software to interpret and often visualize the collected data

Functions

Wearables perform four main functions. The further a product moves toward screening, detection, or prediction of disease, the more likely it is to be a regulated medical device.

Examples

Wearables come in many forms: smart watches, rings, bracelets and bands, smart glasses, chest patches, smart shirts, belts, pants, socks, shoes, and finger-worn devices.

What they are used for matters more than the form:

• Typically regulated as medical devices: continuous glucose monitors, wearable ECG monitors, smart insulin pumps, pulse oximeters, and wearables that provide disease-specific notifications or screening.
• Typically general wellness: fitness trackers used only for general wellness, meditation and sleep aids, and foam rollers and yoga props.

What does the US FDA say about Wearable Medical Devices and Wellness Products?

The FDA separates the two by intended use and risk. The table below compares them:

To decide where a software function or wearable feature falls, the FDA offers a decision-point tool, the Digital Health Policy Navigator. Together with the FDA's policy on device software functions and mobile medical applications, it helps developers decide whether their function is within FDA oversight or covered by enforcement discretion.

FDA Classification and Regulatory Pathways for Wearables

When a Wearable Is Considered a Medical Device

The test is intended use, judged from claims, labeling, marketing, and the product's design. A wearable is likely to be a medical device when it:

• Claims to diagnose, screen for, treat, or monitor a disease or condition
• Gives disease-specific alerts or uses diagnostic thresholds
• Controls or interacts with another regulated device, such as an insulin pump
• Turns a general-purpose device, such as a smartphone with sensors, into a medical device, for example an ECG
• Performs patient-specific analysis or decision-making, such as dosing algorithms or diagnostic interpretation
• Uses invasive or implanted technology

Wording matters. The FDA has written to companies whose wellness wearables drifted into medical claims, such as "medical grade" insights for a condition.

Risk-Based Regulatory Considerations

Wearable medical devices are classified by risk into Class I, II, or III. Most fall in Class II, and highest-risk devices such as implants fall in Class III. Factors that raise risk include:

Premarket and Post-Market Requirements

Premarket. Depending on classification and novelty, the route is an FDA 510(k), a De Novo request, or premarket approval (PMA). Expect to provide:

• Device description, intended use, and labeling
• Performance and clinical evidence, including accuracy against a reference
• Software documentation matched to risk, and cybersecurity documentation
• Human factors and usability engineering evidence
• Electrical, wireless, and biocompatibility testing, as applicable

Quality system and identification. Manufacturers operate under the Quality Management System Regulation (21 CFR Part 820, built on ISO 13485), register and list with the FDA, and apply UDI, including submitting GUDID records.

Post-market. Manufacturers must handle complaints, report adverse events, manage corrections and removals, control software changes, and manage cybersecurity vulnerabilities. See the FAQ section for detail.

Factors

The FDA looks at a small set of factors when deciding how a wearable is treated:

• Intended use and claims: what the labeling, marketing, and features say the product does
• Risk to users: the harm that could result if the product fails or is misleading
• Technology: invasive versus non-invasive sensing, and other technologies that pose safety risk
• Function: what the software or sensor actually does with the data
• Users and setting: who uses it, and where

Wearable Medical Device

A wearable becomes a medical device through its medical purpose. Typical examples are continuous glucose monitors, wearable ECG monitors, smart insulin pumps, and pulse oximeters. Once it is a device, it needs the appropriate premarket pathway, a quality system, and post-market controls, and its claims must be supported by evidence.

Wellness Products

The FDA's General Wellness policy generally leaves low-risk products alone if they are intended only for general wellness. It covers two kinds of intended use:

• Purely wellness claims, such as fitness, weight management, sleep, or relaxation and stress management
• Claims tied to a healthy lifestyle that may reduce risk of, or help someone live well with, certain chronic conditions

The January 2026 revision adds guidance for wearables that sense, estimate, or output physiologic values such as blood pressure, oxygen saturation, blood glucose, or heart rate variability. Such a product can still be a wellness product if it:

• Uses non-invasive sensing
• Is intended only for wellness and avoids disease references and diagnostic thresholds
• Has validated values and consistent labeling, marketing, and notifications

Invasive technologies, such as microneedle glucose sensing, are not low risk and remain regulated as devices. A wellness label does not remove the need for accurate data and honest claims.

Key Concepts in FDA Guidance for Wearables Device Software

Function-Specific / Platform-Agnostic Approach:

The FDA emphasizes that whether software is regulated depends on what it does, not which platform it runs on, whether that is a mobile app or embedded wearable software. A wearable that measures ECG or glucose and interprets the data is more likely to be regulated than one that only counts steps.

When the Software Function Is Likely Regulated?

Some software and embedded wearable functions are more clearly under FDA oversight. A function is likely regulated when it:

• Controls or interacts with other regulated devices, for example controlling an insulin pump
• Transforms a general-purpose device, such as a smartphone with sensors, into a medical device, such as an ECG
• Performs patient-specific analysis or decision-making, such as dosing algorithms or diagnostic interpretation

AI / ML Considerations

Many wearables use AI or machine learning to infer medical conditions or guide treatment. The FDA has issued draft guidance on lifecycle management and marketing submissions for AI-enabled device software functions, and final guidance on predetermined change control plans (PCCPs) for them. Together these emphasize:

• Documenting algorithm design, training data, and validation
• Monitoring performance over time
• Managing updates, drift, and retraining, including through a PCCP that pre-defines allowed changes
• Managing safety and risk across the product life cycle

If your wearable's software uses AI or machine learning to infer medical conditions or guide treatment, this guidance is directly relevant. Check the current status of the draft before you finalize your plan.

Multiple-Function Devices & Mixed Software

Wearables often combine non-medical (wellness) and medical functions. The FDA's policy on multiple-function device products addresses how to treat them. In general, the FDA does not regulate the non-device functions, but it does evaluate whether they could compromise the safety or effectiveness of the regulated function, for example through shared sensors, battery, notifications, or software. Design and document the wellness features so they cannot interfere with the medical ones.

Obstacles Associated with Wearable Medical Devices

Conclusion

Wearable medical devices are a growing part of digital health, offering tools for continuous monitoring and better patient outcomes. To realize that potential, manufacturers must align with regulatory frameworks such as FDA and CE requirements, ensuring safety, efficacy, and data security. Clear labeling, validated claims, and post-market surveillance are essential for building trust with regulators and users. Advances in sensors, connectivity, and AI are enabling devices that not only monitor but predict health trends.

Wellness wearables play an increasingly important role in healthier lifestyles by helping people track and manage things like activity, sleep, stress, and nutrition. Their focus is general wellness rather than diagnosing or treating disease, which keeps them widely accessible. Their value depends on consistent user engagement and the accuracy of the data they collect. For every wearable, intended use and claims decide which side of the line a product sits on.

Frequently Asked Questions

1. When does a wearable device become an FDA-regulated medical device?

When it is intended to diagnose, cure, mitigate, treat, or prevent a disease or condition, or to affect the structure or function of the body, and it does not fit the general wellness policy. The FDA judges this from your claims, labeling, marketing, and what the product actually does. Signs that a wearable is a device include:

• Disease-specific claims, alerts, or diagnostic thresholds
• Screening for a condition, such as atrial fibrillation or sleep apnea
• Controlling another regulated device, or patient-specific dosing or analysis
• Invasive technology

Adding a feature can change the status of a product that was previously wellness-only, so review claims with every update.

2. What FDA requirements apply to wearable medical device manufacturers?

• Classification and premarket authorization: a 510(k), De Novo request, or premarket approval, depending on risk and novelty
• Quality management system: the QMSR (21 CFR Part 820), which builds on ISO 13485, including design controls, risk management under ISO 14971, and software life cycle controls under IEC 62304
• Software documentation: matched to the software's risk, plus cybersecurity documentation for connected devices
• Human factors: usability engineering evidence, including formative and summative evaluation for devices used by lay users
• Testing: performance, biocompatibility, electrical safety, and wireless testing as applicable
• Labeling and identification: compliant labeling, establishment registration and device listing, and UDI, including GUDID submissions

3. What post-market requirements apply to FDA-regulated wearable devices?

• Adverse event reporting: Report deaths, serious injuries, and certain malfunctions through medical device reporting.
• Complaint handling: Record, evaluate, and investigate complaints under the quality system, including the UDI in complaint records.
• Corrections and removals: Report certain field actions taken to reduce health risk.
• Software and change control: Assess every software update to see whether it needs a new submission, and for AI functions follow a PCCP if one was authorized.
• Cybersecurity: Monitor and remediate vulnerabilities, and provide updates and patches.
• Performance monitoring: For AI and other algorithm-driven functions, track real-world performance and drift.
• Other post-market duties: These include any post-approval or post-market studies the FDA requires, and keeping quality records under control, including electronic records under 21 CFR Part 11.

4. What are the FDA rules on wearables?

There is no single rule for wearables. The FDA applies its general device rules, based on what a product is intended to do:

• Medical wearables are regulated as devices, with classification, premarket authorization, a quality system, and post-market controls.
• General wellness wearables that are low risk and make only wellness claims are generally not regulated as devices. The January 2026 revised policy explains when non-invasive physiologic tracking can still count as wellness.
• Software is regulated by its function, not its platform, and the FDA has specific policies for multiple-function products and for AI-enabled software.
• Marketing claims determine which category applies, so keep labeling and promotion consistent with the intended use.